Počet záznamov: 1

etanercept

SYS		d000068800
LBL		00000nx^^^2200181-^^45^^
005		20240119195243.7
100		$a 20160101asloy0103 ba0
152		$b mesh
250		$a etanercept $x AA $x AD $x AE $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo
300	1-	$a 2016 (1997) $8 eng
330	1-	$a A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. $8 eng
450		$a proteín fúzny TNFR-Fc $5 e $8 slo
450		$a TNTR-Fc $5 e $8 slo
686		$a D12.644.541.500.697.624
686		$a D12.776.124.486.485.538.500.624
686		$a D12.776.124.486.485.680.697.624
686		$a D12.776.124.790.651.538.500.624
686		$a D12.776.124.790.651.680.660.624
686		$a D12.776.377.715.548.538.500.624
686		$a D12.776.377.715.548.680.660.624
686		$a D12.776.543.750.705.852.760.232
750		$a Etanercept $8 eng
801	-0	$a SK $b BA006 $c 20160207
801	-2	$a SK $b BA006 $c 20160211
980		$x M

Počet záznamov: 1